Novanta Inc (NOVT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Novanta Inc (NOVT) has a cash flow conversion efficiency ratio of 0.038x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($50.31 Million) by net assets ($1.31 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Novanta Inc (NOVT) liquidity interval to measure how many days the company can operate on defensive assets alone.
Novanta Inc - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Novanta Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Novanta Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novanta Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Installed Building Products Inc
NYSE:IBP
|
0.153x |
|
Gecina SA
PA:GFC
|
0.034x |
|
Bausch + Lomb Corp
TO:BLCO
|
0.021x |
|
Vietnam Rubber Group Ltd
VN:GVR
|
0.040x |
|
Axcelis Technologies Inc
NASDAQ:ACLS
|
0.017x |
|
Casella Waste Systems Inc
NASDAQ:CWST
|
0.040x |
|
Jl Mag Rare-Earth Co Ltd Class A
SHE:300748
|
0.070x |
|
Hindustan Copper Limited
NSE:HINDCOPPER
|
0.144x |
Annual Cash Flow Conversion Efficiency for Novanta Inc (1998–2025)
The table below shows the annual cash flow conversion efficiency of Novanta Inc from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see NOVT stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.31 Billion | $64.06 Million | 0.049x | -77.07% |
| 2024-12-31 | $745.70 Million | $158.51 Million | 0.213x | +19.22% |
| 2023-12-31 | $673.46 Million | $120.08 Million | 0.178x | +13.44% |
| 2022-12-31 | $577.59 Million | $90.78 Million | 0.157x | -13.41% |
| 2021-12-31 | $521.29 Million | $94.62 Million | 0.182x | -38.28% |
| 2020-12-31 | $476.81 Million | $140.24 Million | 0.294x | +94.00% |
| 2019-12-31 | $417.17 Million | $63.25 Million | 0.152x | -37.72% |
| 2018-12-31 | $368.25 Million | $89.65 Million | 0.243x | +37.69% |
| 2017-12-31 | $358.47 Million | $63.38 Million | 0.177x | -4.23% |
| 2016-12-31 | $258.87 Million | $47.79 Million | 0.185x | +35.18% |
| 2015-12-31 | $244.70 Million | $33.42 Million | 0.137x | -31.78% |
| 2014-12-31 | $211.25 Million | $42.29 Million | 0.200x | -1.37% |
| 2013-12-31 | $242.40 Million | $49.20 Million | 0.203x | +62.92% |
| 2012-12-31 | $228.21 Million | $28.43 Million | 0.125x | -42.26% |
| 2011-12-31 | $209.36 Million | $45.17 Million | 0.216x | +469.40% |
| 2010-12-31 | $81.12 Million | $-4.74 Million | -0.058x | -122.96% |
| 2009-12-31 | $152.90 Million | $38.90 Million | 0.254x | 0.00% |
| 2008-12-31 | $152.90 Million | $38.90 Million | 0.254x | +88.84% |
| 2007-12-31 | $278.24 Million | $37.49 Million | 0.135x | +31.11% |
| 2006-12-31 | $343.07 Million | $35.26 Million | 0.103x | +547.68% |
| 2005-12-31 | $306.56 Million | $4.86 Million | 0.016x | -86.30% |
| 2004-12-31 | $305.56 Million | $35.40 Million | 0.116x | +38.41% |
| 2003-12-31 | $260.79 Million | $21.83 Million | 0.084x | +81.78% |
| 2002-12-31 | $254.48 Million | $11.72 Million | 0.046x | +174.37% |
| 2001-12-31 | $282.33 Million | $-17.48 Million | -0.062x | -75.22% |
| 2000-12-31 | $289.27 Million | $-10.22 Million | -0.035x | -37.87% |
| 1999-12-31 | $171.70 Million | $-4.40 Million | -0.026x | +55.74% |
| 1998-12-31 | $120.90 Million | $-7.00 Million | -0.058x | -- |
About Novanta Inc
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets la… Read more